Christina Lake Cannabis (CLC) AI Stock Analysis

• Market Cap: $11.16M
• Dividend Yield: N/A
• Average Volume (3M): 43.87K
• Price to Earnings (P/E): 4.3
• Beta (1Y): -1.31
• Revenue Growth: 22.41%
• EPS Growth: N/A
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 248,093,570
• 10 Day Avg. Volume: 14,844
• 30 Day Avg. Volume: 43,865
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.10
• Enterprise Value/Revenue: 0.76
• Enterprise Value/Gross Profit: 1.34
• Enterprise Value/Ebitda: 5.86
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 54 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

Christina Lake Cannabis has a mixed financial performance with positive revenue growth but pressured profitability margins. The technical analysis indicates a neutral trend with mild bullish momentum. The stock appears undervalued based on its P/E ratio, but the lack of a dividend yield may deter income investors. Focus on improving cash flow management and operational efficiency could enhance the company's financial health.

Christina Lake Cannabis Business Overview & Revenue Model

Company Description

Christina Lake Cannabis Corp. engages in growing, harvesting, processing, and selling cannabis products in the British Columbia, Canada. It offers cannabis oil, hemp oil, and other hemp and cannabis derived products, as well as distillate oils. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is headquartered in Vancouver, Canada.

How the Company Makes Money

Christina Lake Cannabis generates revenue primarily through the sale of its cannabis products to wholesalers, retailers, and directly to consumers. The company leverages its licensed production capabilities to cultivate and process cannabis, which is then sold in various forms, including dried flower, oils, and edibles. Key revenue streams include wholesale distribution agreements with provincial distributors and retail partnerships that allow CLC to expand its market reach. Additionally, the company may benefit from strategic partnerships with other cannabis businesses for co-branding or joint ventures, enhancing its product offerings and market presence. Factors contributing to its earnings include the increasing demand for cannabis products, effective marketing strategies, and compliance with regulatory requirements.

Christina Lake Cannabis Financial Statement Overview

Summary

Christina Lake Cannabis shows mixed financial performance. Revenue growth is positive, but profitability margins are under pressure. The balance sheet is stable with moderate leverage, but cash flow management needs improvement.

Income Statement

Christina Lake Cannabis shows a mixed performance in its income statement. The company has achieved a positive revenue growth rate of 6.89% in the TTM, indicating a growth trajectory. However, the gross profit margin has decreased significantly from 68.41% in 2024 to 34.22% in the TTM, reflecting increased cost pressures. The net profit margin remains low at 6.36%, suggesting limited profitability. The EBIT margin is negative, indicating operational challenges, although the EBITDA margin is positive, showing some operational efficiency.

Balance Sheet

The balance sheet of Christina Lake Cannabis reveals a moderate financial position. The debt-to-equity ratio is stable at 0.95, indicating a balanced leverage. The return on equity has improved to 10.65% in the TTM, showing better utilization of equity. However, the equity ratio is not explicitly provided, but the total assets and equity suggest a moderate equity base. The company should focus on maintaining its leverage and improving equity returns.

Cash Flow

The cash flow statement indicates a positive trend with a 12.92% growth in free cash flow in the TTM. The operating cash flow to net income ratio is low, suggesting that cash generation from operations is not fully aligned with net income. The free cash flow to net income ratio is negative, indicating potential cash flow challenges despite improvements. The company needs to enhance its cash flow management to support growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	16.15M	13.61M	11.78M	10.07M	3.63M	0.00
Gross Profit	9.13M	9.31M	3.61M	2.98M	56.72K	4.77M
EBITDA	2.09M	3.25M	-2.62M	-938.92K	-5.97M	-2.14M
Net Income	47.72K	865.00K	-4.13M	-1.74M	-6.78M	-5.32M
Balance Sheet
Total Assets	22.08M	23.37M	15.96M	18.79M	18.97M	17.80M
Cash, Cash Equivalents and Short-Term Investments	3.39M	1.85M	1.47M	1.84M	1.08M	1.84M
Total Debt	8.22M	10.27M	6.15M	6.45M	3.81M	4.06M
Total Liabilities	10.02M	12.57M	8.50M	7.66M	9.23M	8.35M
Stockholders Equity	12.06M	10.79M	7.46M	11.14M	9.74M	9.46M
Cash Flow
Free Cash Flow	6.66M	-4.13M	781.46K	394.55K	-5.85M	-8.10M
Operating Cash Flow	3.96M	221.02K	1.38M	1.18M	-4.62M	-3.32M
Investing Cash Flow	2.68M	-4.47M	-571.37K	-790.41K	-1.20M	-4.78M
Financing Cash Flow	-4.73M	4.59M	-1.15M	369.17K	5.06M	9.20M

Christina Lake Cannabis Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CLC, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.04, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.99 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CLC.

Christina Lake Cannabis Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLC	54 Neutral	$11.16M	4.33	2.50%	―	22.41%	―
AVNT	54 Neutral	9.18M	-0.39	-73.31%	―	31.94%	-45.55%
MPH	51 Neutral	11.48M	-8.49	-7.39%	―	10.84%	48.57%
PWR	47 Neutral	5.85M	-2.78	0.00%	―	-100.00%	68.14%
RVV	46 Neutral	6.28M	-1.56	0.00%	―	0.00%	15.79%
TRIP	41 Neutral	14.43M	-3.89	-21.78%	―	-8.27%	50.55%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Christina Lake Cannabis Corporate Events

Christina Lake Cannabis Extends Debenture Maturity Date

Christina Lake Cannabis announced an extension of the maturity date for its convertible debentures to September 7, 2026, while maintaining the interest rate. This amendment allows for quarterly repayments starting December 7, 2025, which could impact the company’s financial planning and stakeholder expectations positively.

Christina Lake Cannabis Proposes Amendments to Debenture Terms

Christina Lake Cannabis Corp. has announced its intention to amend the terms of its $960,000 convertible debentures issued in 2022, proposing to extend the maturity date by one year while keeping the interest rate unchanged. This strategic move aims to align debt obligations with operational cash flow cycles and recent expansion achievements, pending approval from debenture holders and the Canadian Securities Exchange.

Christina Lake Cannabis Files Annual Financial Statements, Anticipates Cease Trade Order Revocation

Christina Lake Cannabis Corp. has filed its audited financial statements for the year ending February 28, 2025, on SEDAR+. This filing is expected to lead to the revocation of a management cease trade order, allowing the company’s directors and officers to resume trading in the company’s securities.

Christina Lake Cannabis Delays 2024 Financial Filings Amid Audit Challenges

Christina Lake Cannabis announced a delay in filing its 2024 annual financial statements due to extended audit processes and increased workload from recent acquisitions. The company is working with auditors to complete the filings by July 14, 2025, and has applied for a management cease trade order to prevent its CEO and CFO from trading until the filings are submitted.